Skip to main content
TipRanks
Go Ultimate75% OFF

Pharmaron Beijing Co., Ltd. Class H (3759) Income Statement

11 Followers

Pharmaron Beijing Co., Ltd. Class H Income Statement

Last quarter (Q3 2026), Pharmaron Beijing Co., Ltd. Class H's total revenue was ¥4.41B, an increase of 22.87% from the same quarter last year. In Q3, Pharmaron Beijing Co., Ltd. Class H's net income was ¥496.85M. See Pharmaron Beijing Co., Ltd. Class H’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
¥ 14.10B¥ 12.28B¥ 11.54B¥ 10.27B¥ 7.44B
¥ 4.91B¥ 4.20B¥ 4.12B¥ 3.77B¥ 2.68B
¥ 2.98B¥ 2.10B¥ 2.28B¥ 2.02B¥ 1.15B
Depreciation and Amortization¥ 1.18B¥ 1.05B¥ 927.17M¥ 696.18M¥ 497.92M
¥ 3.29B¥ 3.38B¥ 2.95B¥ 2.53B¥ 2.49B
¥ 1.93B¥ 2.10B¥ 1.85B¥ 1.69B¥ 1.91B
¥ -15.76M¥ -13.20M¥ -10.01M¥ -23.50M¥ -3.34M
¥ 1.91B¥ 2.09B¥ 1.84B¥ 1.67B¥ 1.91B
¥ 1.66B¥ 1.79B¥ 1.60B¥ 1.37B¥ 1.66B
Per Share Metrics
Basic EPS¥ 0.94¥ 1.01¥ 1.00¥ 0.90¥ 1.12
Diluted EPS¥ 0.94¥ 1.01¥ 1.00¥ 0.90¥ 1.10
Weighted Average Shares Outstanding1.76B1.79B1.77B1.77B1.78B
Weighted Average Shares Outstanding (Diluted)1.77B1.79B1.78B1.78B1.81B

Currency in CNY

Pharmaron Beijing Co., Ltd. Class H Earnings and Revenue History

05B10B15B6 %12 %18 %24 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin